Course Content
-
Pediatric Heart Failure: “How to approach the management of Pediatric Heart Failure” Understanding heart failure: the basics in pediatric heart failure and congenital heart diseases. Basics of treatment and decision making in clinic cases
- Introduction. Definition of Heart Failure
- Etiology of Heart Failure in pediatric age
- Pathophysiology of Heart Failure
- Heart Failure in Congenital Heart Disease
- Natriuretic peptid system
- Biomarkers in Heart Failure
- Signs and Symptoms in pediatric age
- Classification of severity in pediatric Heart Failure
- Different forms of cardiomyopathies: “Diagnostic techniques and treatments”
- Dilated Cardiomyopathy
- Myocarditis
- Hypertrophic Cardiomyopathy
- Restrictive Cardiomyopathy
- Non-compaction Cardiomyopathy
- Arrhythmogenic Right Ventricular Dysplasia (ARVD)
- Evaluation Cardiomyopathies and Genetics
- Evaluation Quiz
- Arrhythmias in Pediatric Heart Failure: EKG abnormalities
- Indications ICD in adults and pediatric age
- Clinic Cases. Quiz
- Treatment in chronic pediatric Heart Failure
- New treatment: Sacubitril – Valsartan
- New therapies and Experimental
- Summary Pediatric Heart Failure therapies
-
Basic and Advanced Echocardiography in Pediatric Heart Failure Description of basic and advanced echocardiography tools for diagnostic and follow-up of children affected by heart failure
- Journal Club: “Basic and advanced echocardiography in advanced heart failure: an overview”
- LV systolic function
- RV systolic function
- Cardiac Diastolic Function and Diastolic Heart Failure
- Tissue Doppler Imaging (DTI) and diastolic dysfunction
- Summary Echo left diastolic dysfunction
- RV diastolic dysfunction
- Management of pediatric diastolic dysfunction
- Clinic Cases
- dP/dt LV function assessment
- Myocardial Performance Index (Tei Index) Doppler Mitral Flow
- Myocardial Performance Index (Tei Index) DTI
- Basics of Strain and Strain-rate
- Global longitudinal Strain (GLS)
- Cardiac output assessment by Echo
- Advanced Imaging in Pediatric Heart Failure
- Echocardiography: Apps and webs
- Clinic Cases
-
Pediatric Heart Transplant (I) Basic in inmunology and rejection. Indications of pediatric heart transplant and contraindications. Mechanical support in pediatric age. Surgery and perioperative treatment.
- Basis of transplant immunology
- Human leucocytes antigen (HLA)
- Blood group antigen (ABO)
- Graft Rejection
- Donor selection & evaluation
- Tissue typing and cross matching
- Ischemic time and the TransMedics® Organ Care System (OCS™)
- Indications and Contraindications of Pediatric Heart Transplant
- Indications of pediatric Mechanical cardiac support (MCS)
- Types of Devices for pediatric MCS
- VAD selection for pediatric MCS
- Surgery of Heart Transplant in pediatric age and in Congenital heart disease
- Principle Challenge in immunosuppressive therapies
- Induction therapy during surgery, postoperative period and denervated heart
-
Pediatric Heart Transplant (II) Basic of immunosuppression treatment. Management of rejection and infections in pediatric heart transplant. Information for patients and relatives. Outcomes of heart transplant and indications of retransplantation
- Basis of immunosuppression therapy
- Risk of infection after transplantation
- Complication of chronic immunosuppression
- Basis of Rejection and assessment
- Endomyocardial biopsy and rejection
- Treatment of humoral and cellular rejection
- Chronic rejection: Coronary Artery Vasculopathy (CAV)
- Clinic follow-up in patient transplanted
- Cardiac Rehabilitation in pediatric heart transplant
- Survival and Causes of death in pediatric heart transplant
- Indications of retransplantation and survival
- Home Care after Pediatric Heart Transplant
- Palliative care in Pediatric Heart Failure and Heart Transplantation
- Future perspectives. Summary
- Clinic cases
-
Final Quizz Congratulations! You finished the course, check your knowledge with this final test
-
Fellow Evaluation Course Evaluation of the cardiac fellows who attended the course in May 2020
RV systolic function
The assessment of the systolic right ventricle (RV) is more complex than LV due to complex morphology, is not cylindrical form, is triangular with infundibulum in the RVOT. RV systolic function has been evaluated using several parameters.
Two-dimensional fractional area change (FAC) (as a percentage) provides an estimate of RV systolic function. Two-dimensional FAC < 35% indicates RV systolic dysfunction.
TAPSE (tricuspid annular plane systolic excursion) is easily obtainable and is a measure of RV longitudinal function. It is measured from 4-chambers view in M-mode at the level of the tricuspid annulus, and the value is in mm and represents the displacement of the TV annulus toward the apex in systole. TAPSE < 16 mm in adults indicates RV systolic dysfunction, values TAPSE in children depending of age and BSA.
In presence of tricuspid valve regurgitation (TR), the rate of pressure rise in early systole (right dP/dt max) may be used to evaluate global right ventricular contractility. TR jet velocity depends on the pressure gradient between the RV and right atrium. Using continuous wave Doppler TR spectral is acquired to calculate dP/dt: it represents time duration between change of velocity from 1 to 2 m/s on the MR spectral. Likely abnormal if right dp/dt < 400mmHg. Peak systolic annular velocity (S′ wave) measured at the level of the trivcuspid annulus reflects right ventricular contractility, S'< 8mm is related with RV dysfunction (more information in DTI lesson)
Reference:
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults